S. Ferkal

1.7k total citations
33 papers, 863 citations indexed

About

S. Ferkal is a scholar working on Neurology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Ferkal has authored 33 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 22 papers in Rheumatology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in S. Ferkal's work include Neurofibromatosis and Schwannoma Cases (26 papers), Soft tissue tumor case studies (12 papers) and Soft tissue tumors and treatment (9 papers). S. Ferkal is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (26 papers), Soft tissue tumor case studies (12 papers) and Soft tissue tumors and treatment (9 papers). S. Ferkal collaborates with scholars based in France, United States and Netherlands. S. Ferkal's co-authors include P. Wolkenstein, L. Valeyrie‐Allanore, Sylvie Bastuji‐Garin, Béatrice Parfait, P. Combemale, É. Sbidian, Éric Pasmant, Ingrid Laurendeau, Audrey Sabbagh and Michel Vidaud and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Human Molecular Genetics and Annals of the Rheumatic Diseases.

In The Last Decade

S. Ferkal

31 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ferkal France 14 620 324 205 176 138 33 863
Mario Teo United Kingdom 18 601 1.0× 278 0.9× 150 0.7× 189 1.1× 197 1.4× 56 1.1k
Guijun Jia China 20 479 0.8× 333 1.0× 451 2.2× 258 1.5× 112 0.8× 91 1.3k
Emiko Hori Japan 18 511 0.8× 232 0.7× 148 0.7× 294 1.7× 95 0.7× 87 907
David J. Fusco United States 13 404 0.7× 99 0.3× 134 0.7× 81 0.5× 134 1.0× 20 982
Jun Masuoka Japan 17 433 0.7× 88 0.3× 161 0.8× 100 0.6× 239 1.7× 58 902
V. S. Mehta India 19 303 0.5× 127 0.4× 238 1.2× 90 0.5× 117 0.8× 44 823
Allan E. Rubenstein United States 17 658 1.1× 181 0.6× 387 1.9× 148 0.8× 250 1.8× 34 1.0k
Özlem Kurtkaya Türkiye 17 379 0.6× 105 0.3× 166 0.8× 76 0.4× 68 0.5× 32 696
Dong Zhang China 17 627 1.0× 585 1.8× 107 0.5× 320 1.8× 52 0.4× 79 1.0k
Thomas Flannery United States 21 1.0k 1.7× 78 0.2× 539 2.6× 125 0.7× 114 0.8× 38 1.4k

Countries citing papers authored by S. Ferkal

Since Specialization
Citations

This map shows the geographic impact of S. Ferkal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ferkal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ferkal more than expected).

Fields of papers citing papers by S. Ferkal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ferkal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ferkal. The network helps show where S. Ferkal may publish in the future.

Co-authorship network of co-authors of S. Ferkal

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ferkal. A scholar is included among the top collaborators of S. Ferkal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ferkal. S. Ferkal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fertitta, L., Kavita Y. Sarin, Carlos G. Romo, et al.. (2025). Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D. British Journal of Dermatology. 194(4). 679–688.
2.
Fertitta, L., O. Zehou, Christina Bergqvist, et al.. (2024). Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1. Journal of Investigative Dermatology. 144(8). 1754–1761.e1. 3 indexed citations
3.
Fertitta, L., Kavita Y. Sarin, Christina Bergqvist, et al.. (2023). cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. Journal of Investigative Dermatology. 143(11). 2226–2232.e1. 2 indexed citations
4.
Bergqvist, Christina, L. Fertitta, S. Ferkal, et al.. (2023). In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study. Journal of Investigative Dermatology. 143(12). 2408–2415.e7. 4 indexed citations
5.
Bergqvist, Christina, et al.. (2021). Lymphoproliferative malignancies in patients with neurofibromatosis 1. Orphanet Journal of Rare Diseases. 16(1). 230–230. 7 indexed citations
6.
Ferkal, S., Jean–Claude Souberbielle, É. Sbidian, et al.. (2021). Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France. Calcified Tissue International. 108(6). 738–745. 7 indexed citations
7.
Sérézal, Irène Gallais, S. Ferkal, Lionel Lerman, et al.. (2021). [18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis. Orphanet Journal of Rare Diseases. 16(1). 49–49. 1 indexed citations
8.
Bergqvist, Christina, F. Hémery, S. Ferkal, & P. Wolkenstein. (2020). Neurofibromatosis I and multiple sclerosis. Orphanet Journal of Rare Diseases. 15(1). 186–186. 8 indexed citations
9.
Bergqvist, Christina, et al.. (2020). Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet Journal of Rare Diseases. 15(1). 37–37. 104 indexed citations
10.
Parfait, Béatrice, et al.. (2019). Segmental schwannomatosis: characteristics in 12 patients. Orphanet Journal of Rare Diseases. 14(1). 207–207. 17 indexed citations
11.
Blachier, Martin, Florence Canouï‐Poitrine, Maxime Dougados, et al.. (2013). Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort. Lara D. Veeken. 52(9). 1686–1693. 32 indexed citations
12.
Sbidian, É., S. Hadj‐Rabia, Vincent M. Riccardi, et al.. (2012). Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study. Orphanet Journal of Rare Diseases. 7(1). 62–62. 12 indexed citations
13.
Blachier, Martin, Maxime Dougados, Alain Saraux, et al.. (2012). Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort. Annals of the Rheumatic Diseases. 72(6). 979–985. 25 indexed citations
14.
Pasmant, Éric, Audrey Sabbagh, Julien Masliah‐Planchon, et al.. (2011). Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1. JNCI Journal of the National Cancer Institute. 103(22). 1713–1722. 89 indexed citations
15.
Duong, T.A., É. Sbidian, L. Valeyrie‐Allanore, et al.. (2011). Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France. Orphanet Journal of Rare Diseases. 6(1). 18–18. 79 indexed citations
16.
Duong, T.A., Sylvie Bastuji‐Garin, L. Valeyrie‐Allanore, et al.. (2011). Evolving Pattern with Age of Cutaneous Signs in Neurofibromatosis Type 1: A Cross-Sectional Study of 728 Patients. Dermatology. 222(3). 269–273. 57 indexed citations
17.
Sbidian, É., P. Wolkenstein, L. Valeyrie‐Allanore, et al.. (2010). NF-1Score: A Prediction Score for Internal Neurofibromas in Neurofibromatosis-1. Journal of Investigative Dermatology. 130(9). 2173–2178. 25 indexed citations
18.
Sabbagh, Audrey, Éric Pasmant, Ingrid Laurendeau, et al.. (2009). Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Human Molecular Genetics. 18(15). 2768–2778. 97 indexed citations
19.
Wolkenstein, P., et al.. (2008). Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. British Journal of Dermatology. 160(4). 844–848. 53 indexed citations
20.
Valeyrie‐Allanore, L., Nicolás Ortonne, Laurent Lantieri, et al.. (2008). Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance. British Journal of Dermatology. 158(5). 1008–1012. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mario Teo Breakdown of academic impact, for papers by Guijun Jia Breakdown of academic impact, for papers by Emiko Hori Breakdown of academic impact, for papers by David J. Fusco Breakdown of academic impact, for papers by Jun Masuoka Breakdown of academic impact, for papers by V. S. Mehta Breakdown of academic impact, for papers by Allan E. Rubenstein Breakdown of academic impact, for papers by Özlem Kurtkaya Breakdown of academic impact, for papers by Dong Zhang Breakdown of academic impact, for papers by Thomas Flannery
Rankless by CCL
2026